These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. HLA markers and prediction of clinical course and outcome in rheumatoid arthritis. Wagner U; Kaltenhäuser S; Sauer H; Arnold S; Seidel W; Häntzschel H; Kalden JR; Wassmuth R Arthritis Rheum; 1997 Feb; 40(2):341-51. PubMed ID: 9041946 [TBL] [Abstract][Full Text] [Related]
4. Role of HLA-DR-DR and DR-DQ associations in the expression of extraarticular manifestations and rheumatoid factor in rheumatoid arthritis. Perdriger A; Chalès G; Semana G; Guggenbuhl P; Meyer O; Quillivic F; Pawlotsky Y J Rheumatol; 1997 Jul; 24(7):1272-6. PubMed ID: 9228123 [TBL] [Abstract][Full Text] [Related]
5. Associations of HLA-DRB and -DQB genes with two and five year outcome in rheumatoid arthritis. Eberhardt K; Fex E; Johnson U; Wollheim FA Ann Rheum Dis; 1996 Jan; 55(1):34-9. PubMed ID: 8572731 [TBL] [Abstract][Full Text] [Related]
6. Association of (Q)R/KRAA positive HLA-DRB1 alleles with disease progression in early active and severe rheumatoid arthritis. Seidl C; Koch U; Buhleier T; Möller B; Wigand R; Markert E; Koller-Wagner G; Seifried E; Kaltwasser JP J Rheumatol; 1999 Apr; 26(4):773-6. PubMed ID: 10229395 [TBL] [Abstract][Full Text] [Related]
7. Expression of QK/QR/RRRAA or DERAA motifs at the third hypervariable region of HLA-DRB1 and disease severity in rheumatoid arthritis. Khani-Hanjani A; Lacaille D; Horne C; Chalmers A; Hoar DI; Balshaw R; Keown PA J Rheumatol; 2002 Jul; 29(7):1358-65. PubMed ID: 12136889 [TBL] [Abstract][Full Text] [Related]
8. Protection against severe disease is conferred by DERAA-bearing HLA-DRB1 alleles among HLA-DQ3 and HLA-DQ5 positive rheumatoid arthritis patients. Seidl C; Körbitzer J; Badenhoop K; Seifried E; Hoelzer D; Zanelli E; Kaltwasser JP Hum Immunol; 2001 May; 62(5):523-9. PubMed ID: 11334677 [TBL] [Abstract][Full Text] [Related]
9. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. van Gaalen FA; van Aken J; Huizinga TW; Schreuder GM; Breedveld FC; Zanelli E; van Venrooij WJ; Verweij CL; Toes RE; de Vries RR Arthritis Rheum; 2004 Jul; 50(7):2113-21. PubMed ID: 15248208 [TBL] [Abstract][Full Text] [Related]
12. HLA-DR-DQ haplotypes and genotypes in Finnish patients with rheumatoid arthritis. Laivoranta-Nyman S; Möttönen T; Hermann R; Tuokko J; Luukkainen R; Hakala M; Hannonen P; Korpela M; Yli-Kerttula U; Toivanen A; Ilonen J; Ann Rheum Dis; 2004 Nov; 63(11):1406-12. PubMed ID: 15479890 [TBL] [Abstract][Full Text] [Related]
13. The effect of HLA-DRB1 disease susceptibility markers on the expression of RA. Rowley MJ; Stockman A; Brand CA; Tait BD; Rowley GL; Sherritt MA; Mackay IR; Muirden KD; Bernard CC Scand J Rheumatol; 1997; 26(6):448-55. PubMed ID: 9433406 [TBL] [Abstract][Full Text] [Related]
14. The impact of HLA-DRB1 genes on extra-articular disease manifestations in rheumatoid arthritis. Turesson C; Schaid DJ; Weyand CM; Jacobsson LT; Goronzy JJ; Petersson IF; Sturfelt G; Nyhäll-Wåhlin BM; Truedsson L; Dechant SA; Matteson EL Arthritis Res Ther; 2005; 7(6):R1386-93. PubMed ID: 16277691 [TBL] [Abstract][Full Text] [Related]
15. DQCAR 113 and DQCAR 115 in combination with HLA-DRB1 alleles are significant markers of susceptibility to rheumatoid arthritis in the Korean population. Kim TG; Choi HB; Park SH; Kim HY; Han H Tissue Antigens; 1999 Dec; 54(6):552-9. PubMed ID: 10674968 [TBL] [Abstract][Full Text] [Related]
16. Prospective analysis of the impact of HLA-DR and -DQ on joint destruction in recent-onset rheumatoid arthritis. Wagner U; Kaltenhäuser S; Pierer M; Seidel W; Tröltzsch M; Häntzschel H; Kalden JR; Wassmuth R Rheumatology (Oxford); 2003 Apr; 42(4):553-62. PubMed ID: 12649403 [TBL] [Abstract][Full Text] [Related]
17. HLA-DRB1 alleles encoding an aspartic acid at position 70 protect against development of rheumatoid arthritis. Mattey DL; Dawes PT; Gonzalez-Gay MA; Garcia-Porrua C; Thomson W; Hajeer AH; Ollier WE J Rheumatol; 2001 Feb; 28(2):232-9. PubMed ID: 11246655 [TBL] [Abstract][Full Text] [Related]
18. HLA-DQ-associated predisposition to and dominant HLA-DR-associated protection against rheumatoid arthritis. van der Horst-Bruinsma IE; Visser H; Hazes JM; Breedveld FC; Verduyn W; Schreuder GM; de Vries RR; Zanelli E Hum Immunol; 1999 Feb; 60(2):152-8. PubMed ID: 10027783 [TBL] [Abstract][Full Text] [Related]
19. Rheumatoid arthritis in southern Spain: toward elucidation of a unifying role of the HLA class II region in disease predisposition. Pascual M; Nieto A; López-Nevot MA; Ramal L; Matarán L; Caballero A; Alonso A; Martín J; Zanelli E Arthritis Rheum; 2001 Feb; 44(2):307-14. PubMed ID: 11229460 [TBL] [Abstract][Full Text] [Related]
20. Independent association of rheumatoid factor and the HLA-DRB1 shared epitope with radiographic outcome in rheumatoid arthritis. Mattey DL; Hassell AB; Dawes PT; Cheung NT; Poulton KV; Thomson W; Hajeer AH; Ollier WE Arthritis Rheum; 2001 Jul; 44(7):1529-33. PubMed ID: 11465703 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]